OPKO Health, Inc.
OPK · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $151,669 | $156,807 | $149,952 | $183,638 |
| % Growth | -3.3% | 4.6% | -18.3% | – |
| Cost of Goods Sold | $80,402 | $107,405 | $107,332 | $98,979 |
| Gross Profit | $71,267 | $49,402 | $42,620 | $84,659 |
| % Margin | 47% | 31.5% | 28.4% | 46.1% |
| R&D Expenses | $30,078 | $30,342 | $30,841 | $30,425 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $53,804 | $59,597 | $59,086 | $67,029 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$60,671 | $19,444 | $19,861 | $20,344 |
| Operating Expenses | $23,211 | $109,383 | $109,788 | $117,798 |
| Operating Income | $48,056 | -$59,981 | -$67,168 | -$33,139 |
| % Margin | 31.7% | -38.3% | -44.8% | -18% |
| Other Income/Exp. Net | -$6,625 | -$102,539 | -$6,206 | $68,123 |
| Pre-Tax Income | $41,431 | -$162,520 | -$73,374 | $34,984 |
| Tax Expense | -$19,797 | -$14,079 | -$5,761 | $20,946 |
| Net Income | $61,228 | -$148,441 | -$67,613 | $14,027 |
| % Margin | 40.4% | -94.7% | -45.1% | 7.6% |
| EPS | 0.03 | -0.22 | -0.1 | 0.02 |
| % Growth | 113.6% | -120% | -595% | – |
| EPS Diluted | 0.03 | -0.22 | -0.1 | 0.02 |
| Weighted Avg Shares Out | 777,155 | 671,577 | 671,577 | 797,442 |
| Weighted Avg Shares Out Dil | 779,919 | 671,577 | 671,577 | 694,020 |
| Supplemental Information | – | – | – | – |
| Interest Income | $3,023 | $3,287 | $4,681 | $4,294 |
| Interest Expense | $11,358 | $70,327 | $15,466 | $14,240 |
| Depreciation & Amortization | $22,740 | $23,027 | $23,487 | $24,039 |
| EBITDA | $75,529 | -$69,166 | -$34,421 | $73,179 |
| % Margin | 49.8% | -44.1% | -23% | 39.8% |